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A cooperative dialogue between natural killer (NK) cells and dendritic cells (DCs) has been elucidated in the last years. They help
each other to acquire their complete functions, both in the periphery and in the secondary lymphoid organs. Thus, NK cells’
activation by dendritic cells allows the killing of transformed or infected cells in the periphery but may also be important for
the generation of adaptive immunity. Indeed, it has been shown that NK cells may play a key role in polarizing a Th1 response
upon interaction with DCs exposed to microbial products. This regulatory role of DC/NK cross-talk is of particular importance
at mucosal surfaces such as the intestine, where the immune system exists in intimate association with commensal bacteria such
as lactic acid bacteria (LAB). We here review NK/DC interactions in the presence of gut-derived commensal bacteria and their
role in bacterial strain-dependent immunomodulatory eﬀects. We particularly aim to highlight the ability of distinct species of
commensalbacterial probiotics to diﬀerently aﬀect the outcomeofDC/NK cross-talkandconsequentlyto diﬀerently inﬂuence the
polarization of the adaptive immune response.
1.Introduction
Dendritic cells (DCs) and natural killer (NK) cells play a
critical role in early defenses against cancer and infections,
and evidence of interactions between these two cell types
has accumulated in the last years [1–7]. This interaction
might results in NK cell activation, DC maturation, or
DC death, depending on the activation status of both cell
types. Thus, the outcome of NK/DC crosstalk is likely to
inﬂuence the innate as well as the subsequent adaptive
immune responses [8]. This crosstalk can be promoted
by pathogen-derived products that activate diﬀerent innate
immune cell types directly and simultaneously through their
Toll-like receptors (TLRs) [9]. Indeed, DCs and NK cells
have developed diﬀerent, but partially overlapping, systems
to identify pathogen-associated danger signals and they are,
therefore, diﬀerently involved in the detection of various
microorganisms.
DCs are critical for initiating immune responses against
both pathogenic and nonpathogenic bacteria. In an imma-
ture stage, DCs reside in peripheral tissues, continuously
sampling the microenvironment, sensing the presence of
pathogens, and releasing chemokines and cytokines to
amplify the immune response [10]. It has been clearly evi-
denced that, depending on the nature of the stimuli received,
myeloid DCs can develop into diﬀerent subsets that possess
unique biological functions, determined by the combination
of surface molecule expression and cytokine secretion [10].
In part, these diﬀerent outcomes are inﬂuenced by exposure
of the DCs to microbial products. Therefore, the regulatory
role of DCs is of particular importance at mucosal surfaces
such as the intestine, where the immune system exists in
intimate association with the commensal bacteria such as
lactic acid bacteria (LAB) [11]. Interestingly, recent studies
have demonstrated that diﬀerent strains of LAB posses the
ability to ﬁnely regulate myeloid DCs maturation, polarizing2 Journal of Biomedicine and Biotechnology
the subsequent T cell activity toward Th1, Th2, or even Treg
responses [12–14].
Natural killer (NK) cells distinguish between normal
healthy cells and abnormal cells by using a sophisticated
repertoire of cell surface receptors [15, 16], playing a key
role in the immune response to certain infections and
malignancies by direct cytolysis of infected or transformed
cells and by secretion of potent immune mediators [7].
Human gut-associated lymphoidtissues harbour various NK
cell subsets, which are certainly involved in maintaining
homeostasis between the intestinal microbiota and the
mucosal immune system [17]. In addition, a human NK-like
cell subset expressing NKp44 and IL-22 but lacking classic
NK cells molecules such as perforin has been more recently
identiﬁed [18–20]. Gut-associated NK cells might play
an important role in mucosal homeostasis and protective
immune responses, particularly under microbial challenge.
In addition, although evidence of a direct action of
commensal bacteria, including LAB, on NK cells is still
elusive, recent studies suggested that LAB-induced DC
regulation might aﬀect NK cell activity. It has been reported
that DCs matured by LAB consistently induce activation
and promote proliferation and cytotoxicity in autologous
NK cells, and that strains of diﬀerent LAB species diﬀer
importantly in their capacity to induce IFN-γ production in
NK cells via DCs [14].
This review addresses NK/DC interactions in response
to gut-derived LAB and the implications of LAB strain-
dependent immunomodulatory eﬀects. Finally, we discuss
the potential in vivo impact of commensal bacteria on NK/
DCinterplay in mucosal tissues, with particular regard to the
ability of distinct species of commensal bacterial probiotics
to diﬀerently polarize the adaptive immune response.
2.NK-DC Interactions:Molecular Mechanisms
Several in vitro studies show a central role of DC-derived
IL-12, IL-18, and type I IFN in the triggering of NK
cell functions. IL-12 seems to be important to induce the
secretion of IFN-γ by NK cells in several systems: LPS-
activated monocyte-derived DCs, splenic DCs [21, 22], or
poly(I:C)-stimulated myeloid DC [22]. IL-18 may act in
synergy with IL-12 to induce the secretion of IFN-γ by NK
cells but also to enhance cytotoxicity, at least when NK cells
are stimulated with human CD34+ derived DCs [23]. Type I
IFNs have also been shown to enhance cytotoxicity of NK
cells [3, 24]. Although all types of DCs can secrete type I
IFN, the main producer of these cytokines are plasmacytoid
dendritic cells (pDCs), particularly when activated through
TLR7and TLR9 byvirus components [25].Nevertheless,NK
cells may be activated in an IL-12-, IL-18- and type I IFN-
independent manner. In fact, DCs from IL-12- and IL-18-
deﬁcientmice are able to induceIFN-γ secretion by NKcells.
In mice, this capability might be under the control of IL-2
secreted by bone marrow-derived DCs activated by bacterial
components [26].
IL-15 produced by mature monocyte-derived DCs
appears to be particularly important to stimulate NK
cell proliferation. Interestingly, this eﬀect may require the
membrane-bound form of IL-15, as the proliferation is
abrogated by physical separation of DCs and NK cells [21].
Despite the large mass of data showing the role of
soluble factors in NK cells activation, early studies in mice
suggest the involvement of cell-to-cell contact [1]. Transwell
separation of the two populations could abrogate DC-
dependent NK cells’ cytotoxicity induction [1]. Contact
through an “immunological synapse” may be necessary for
the polarized secretion of IL-12 or of other cytokines by DCs
towardNKcells[27]aswellasforligand-receptorinteraction
[28].
Likewise,itisprobablythroughsuch synaptic formations
that NK cells may kill DCs. Several groups have observed
that NK cells recognize and lyse monocyte-derived DCs in
vitro[2,29]inacell-to-cellcontactdependentmanner. Ithas
been described that NK/DCratio is a critical factor to induce
NK cells-mediated DC death. Whereas a low ratio (1:5)
leads to DCs maturation, a higher NK/DCratio (5:1) causes
killing of immature DCs by the autologous NK cells [29].
Interestingly, DC subsets display diﬀerent susceptibilities
to lysis by NK cells; human pDCs were not lysed by IL-
2 activated NK cells whereas mDCs isolated directly from
blood underwent only a limited lysis [22].
Moreover, mature DCs are protected from NK cell lysis
by acquiring a higher expression of HLA I molecules [30].
Beside the inhibitory receptors, NK cells activating receptors
play a primary role in DC targeting. The activating receptor
NKp30 appears to be an important candidate during this
interaction, since the single blocking of this receptor inhibits
NK cell-mediated lysis of immature DCs [2].
In peripheral tissues, the bidirectional crosstalk between
NK cells and DCs has been proposed to play a relevant role
in the mechanisms leading to the selection of DCs with
maximal capability of T cell priming [4, 31]. In particular,
distinct studieshavedemonstrated thathuman NKcellshave
the capability to induce DC maturation [22, 29, 32]. This
might be important when pathogen-related molecules or
inﬂammation are not present to drive DC maturation and,
therefore, an eﬀective antigen presentation.
The molecular mechanisms that regulate this speciﬁc
part of the human NK/DC crosstalk have been also clariﬁed.
It has been found that, at low NK/DC ratio, NK-DC
interactions induces cytokine production (especially, TNF-α
and IL-12) by DCs as well as the upregulation of a series of
molecules involved in antigen presentation. This stimulating
eﬀect may depend on cell-to-cell contact as well as TNF-α
released by NK cells [29, 32].
3.CrosstalkbetweenNK Cellsand
PlasmacytoidDCs
ThecrosstalkofNKcellswithpDCshasnotbeeninvestigated
as much as with myeloid DCs. Remarkably, NK cells and
pDCs share diﬀerent speciﬁc receptors and are thus likely to
respond to similar stimuli and possibly to be involved in the
same phases of the innate immune response [33, 34].
Cytolytic activity of NK cells has long been known to be
enhanced by IFN-α [35], and pDCs, also known as type I
interferon-producing cells [36, 37], have been shown to beJournal of Biomedicine and Biotechnology 3
required for NK cell-mediated lysis of virus-infected target
cells [38].
In humans, the pDC pattern of TLR expression is
profoundly diﬀerent from that of myeloid DCs. pDCsdo not
expressTLR1,2,3,4,5,or6butexpressTLR7thatrecognizes
viral RNAand TLR9 that recognizes CpG-rich unmethylated
DNA from bacteria and DNA viruses. Signaling by TLRs
expressed on pDCs drives the production of type I IFN that
can directly activate antiviral responses and augment both
innate and adaptive immunity to viral as well as nonviral
infections [25]. Similar to NK cells [39], pDCs express
TLR9. Because both NK cells and pDCs express TLR9, under
appropriate conditions, they can potentially be activated by
the same invading pathogen simultaneously. The abundant
r e l e a s eo ft y p eII F Nb yp D C s[ 40], stimulated through
TLR9 [41], suggests that the NK cells/pDCs interaction
can result in enhanced antiviral innate protection. Through
TLR9,theNK/pDCinteraction resultsin upregulationofNK
cell-mediated cytotoxicity against various tumor cell targets
[3, 24, 42]. This eﬀect is strongly reduced by antibodies
against IFN-α, thus indicating a primary role for this
cytokineinregulating NKcellfunctions[24].Indeed,asharp
up-regulation of CD69 surface expression, conﬁrmed that,
underthese conditions,NKcells becomeactivated. However,
only the small CD56bright NK cell subset can proliferate in
the presence of pDCs and TLR9 ligands [24]. Nevertheless,
pDC-induced NK cell proliferation appears to be IL-15-
independent since, diﬀerently from monocyte-derived DCs
[21], surface IL-15 is not detectable in TLR-stimulated pDCs
[43]. In turn, NK cells are capable of promoting pDC
maturation and of up-regulating their production of IFN-α
in response to CpG [22]. It is of note that, although NK cells
cannot exert an editing program on pDCs,owing tothe poor
susceptibility of these cells to NK cell-mediated lysis, when
cocultured with TLR9-stimulated pDCs, NK cells acquire
lytic activity against monocyte-derived immature DCs [24].
4.LacticAcidBacteriaand Probiotics
The gastrointestinal tract constitutes an important interface
between host and environment and, as such, has the dual
role of excluding pathogens while facilitating the absorption
of nutrients. It is colonized by an estimated 1014 microbes,
with the density ofcolonization increasing from the stomach
to the distal colon. Commensal bacteria participate in
both tasks of the gastrointestinal tract: some help in the
absorption of otherwise indigestible nutrients, especially
complex carbohydrates, and some contribute to coloniza-
tion resistance, that is, the ability to inhibit colonization
or overgrowth of allegedly pathogenic microorganisms by
(i) producing antimicrobial substances, (ii) competing for
adhesion sites and nutrients, and (iii) by stimulating the
immune system.
Lactic acid bacteria (LAB) are a group of commen-
sal bacteria characterized by their main metabolite and
comprise bacteria belonging to several genera (Lactococcus,
Streptococcus, Enterococcus, Leuconostoc, and Lactobacillus).
Moreover, the genus Biﬁdobacterium is often mentioned
in LAB contexts, although the main fermentation product
of biﬁdobacteria is acetic acid. LAB (hereafter, comprising
biﬁdobacteria) are predominantly nonpathogenic, Gram
positive, catalase negative, nonsporeforming, facultative
anaerobe, and obligate fermentative. These bacteria have
traditionally been applied in food fermentations due to
their lactic acid production contributing acidity and thereby
prolonged conservation to the foodstuﬀ, and to the pleasant
ﬂavor of other metabolites [44]. Some strains of lactobacilli
and biﬁdobacteria are acid and bile tolerant and can be
isolated from the mammal gastrointestinal system. In the
stomach and in the upper part of the small intestine,
lactobacilli outnumber other bacteria whereas biﬁdobacteria
are mainly present in the anaerobic colon, as the dominant
genus in breast-fed infants and in adulthood coexisting with
many other bacterial strains [45]. As a consequence, food
containing viable LAB, such as yoghurt, has gained a reputa-
tion of beneﬁting intestinal well-being, and LAB strains with
assumed healtheﬀectshavebeentermed“probiotic”(prolife,
as opposed to antibiotic). The deﬁnition of probiotics
c u r r e n t l ye m p l o y e db yt h eW o r l dH e a l t hO r g a n i z a t i o ni s
“live microorganisms, which when administered in adequate
amounts, confer a health beneﬁt on the host” [46].
“Probiotic” can also designate other microorganisms,
for instance certain strains of E. coli and Saccharomyces
cerevisiae, butthe majority ofcommercial probioticsare LAB
[47].The eﬀectofLABonintestinal healthcanbeassigned to
their ability to competitively exclude pathogenic bacteria, to
degrade indigestible food components (i.e., ﬁbre or lactose
in lactose-intolerant individuals) to valuable nutrients, and
ﬁnally to support epithelial cell survival and intestinal wall
integrity [48].
Data from studies in gnotobiotic, that is, noncolonized
rodents and rodents with a controlled microbiota, however,
suggest that LAB and other non-pathogenic, so-called com-
mensal, gut bacteria enter in a complex relationship with
their animal host, beneﬁting health also via interactions
with both the intestinal and the systemic immune system.
If the immune system is not stimulated by gut bacteria
after birth it does not develop completely, comprises fewer
T cells (including Tregs) [49, 50], dendritic cells [51],
and generates weaker antibody responses [52]. Interestingly,
speciﬁc recognition of commensal microorganisms occurs
only in the gut and in the mesenteric lymph nodes [53], and
this microbial stimulation might skew the immune system
away from the neonatally dominating Th2 response towards
a balanced Th1 immune proﬁle [54].
5.LABasImmunomodulators
Individual species of LAB bacteria possess varying immuno-
modulatory properties and may ﬁnely polarize the immune
response. LAB mainly exert direct eﬀects on antigen present-
ing cells such as dendritic cells, monocytes, macrophages,
and, to a minor extent, B-cells, without necessarily being
the source of antigen. Cytokines and maturation markers
induced by LAB stimulation on APC are, together with the
type of antigen encountered, determinants of an ensuing
T-cell response [55]. Comparison of stimulation of mono-
cytes/macrophages with LAB as opposed to Gram-negative4 Journal of Biomedicine and Biotechnology
bacteria has shown that LAB preferentially induce IL-12
production whereas Gram-negative bacteria such as E. coli
mainly induce IL-10 [56, 57].
Gastrointestinal-associated lymphoid tissue (GALT) har-
bours two subset of DCs: myeloid DCs (mDCs), expressing
CD11c, and plasmacytoid DCs (pDCs), lacking CD11c and
expressing BDCA-2 and ILT-7 [58]. Since myeloid and
plasmacytoid DCs express diﬀerent repertoires of TLRs, they
are diﬀerently involved in the detection of various pathogens
[59]. LAB stimulation of mDCsyields a complicated picture,
as diﬀerent strains of the same genus or even species of
LAB can induce diﬀerent amounts of IL-10 and IL-12. In
addition to these Th1-Th2/Treg polarizing cytokines, LAB
stimulation frequently leads to TNF-α and IL-6 production
by DCs [60, 61]. Concomitantly with induction of cytokine
production, distinct LAB induce diﬀerent levels of matu-
ration in DCs. Generally, LAB induce “semimature DCs”,
which express lower levels of CD40, CD80, CD86 than DCs
matured with pathogenic Gram-positive bacteria and Gram-
negative bacteria [62], and induction of maturation markers
correlates with their capacity to induce IL-12 and TNF-α.
Among gut-derived LAB, Lactobacillus-dependent induction
ofsurface markers variessigniﬁcantly withthestrain whereas
most biﬁdobacteria induce low levels of DC maturation
[14]. The mucosal microbiota might also modulate IFN-α
production by pDCs [63]. Although recent data have shown
that LAB do not directly trigger activation of pDCs, in vitro
studies have suggested a modulation of type I IFN produc-
tion by the mucosal microenvironment on activated pDCs
[63].
How probiotics could modulate activated pDCs remains
an interesting ﬁeld of investigation: it is hypothesized
that commensal bacteria may act through speciﬁc intra-
cytoplasmic TLRs with the help of humoral immunity
or, alternatively, another intriguing scenario may envisage
the cooperation of myeloid DCs in LAB-mediated pDC
regulation [64].
6.ActiveComponentsof LAB
Consensus has not been reached regarding whether bacteria
have to survive passage of the gastrointestinal tract to be
termed probiotic. However, a picture is emerging where live
bacteriaare obviouslyrequiredtoreach theguttometabolize
ﬁbres and to outgrow pathogens whereas similar in vitro
immunomodulatory eﬀects of LAB can be obtained with
both live and dead bacteria [13]. For some immunomod-
ulatory eﬀects, cell integrity is required [65], but in other
cases, bacterial components are stimulatory by themselves.
Candidate active molecules of LAB are DNA [66, 67]a n d
cell wall components [68, 69]. CpG DNA is a ligand of Toll-
likereceptor(TLR9)and cellwall peptidoglycan,lipoteichoic
acid,andlipopeptidesarerecognisedbyTLR2inconjunction
with TLR1 or TLR6 [70]. LAB-ligation of TLRs results
in translocation of NFκB to the nucleus with secretion of
proinﬂammatory cytokines (IL-1β,T N F α,a n dI L - 6 )a sa
consequence. IL-12 production is also likely to be a product
of TLR-stimulation, as expression of the subunit IL-12p40
in DC in the lamina propria of the small intestine requires
binding of NFκB[ 71], but also intracellular Nucleotide-
binding oligomerisation domain (NOD) receptors may
recognize LAB peptidoglycan [72, 73]. Regarding the sup-
pressive cytokine IL-10, it can be induced when microbes
are recognised by TLR2 or via C-type lectin receptors such
as DC-SIGN [55]. It is intriguing that, apparently, small
diﬀerences in LAB surface structure result in distinct DCs
maturation and cytokine induction patterns, which function
as a kind of “strain-ﬁngerprint” [74], although for most LAB
these mechanisms still remain poorly understood.
7.LABShapingNK/DC Crosstalk
Because LAB have a profound modulatory eﬀect on DCs
and because DCs in turn are potent activators of NK cells,
it is reasonable to expect that DCs that have encountered
LAB and undergo maturation can stimulate NK cells. This
hypothesis has been recently addressed, and it is now clear
that human monocyte-derived DCs [14], blood DCs [75],
mouse splenic [76] and lymph node DCs [77]m a t u r e d
by IL-12-inducing LAB activate NK cells to produce IFN-
γ, which is in accordance with the belief that IL-12 is
essential for IFN-γ production in NK cells. Similarly, LAB-
stimulated monocytes produce IL-12 and induce IFN-γ
production in NK cells [73–75]. Interestingly, intestine-
near mesenteric lymph node NK cells respond to LAB-
matured DC with a stronger IFN-γ production than their
spleen counterparts [77]. LAB, which do not induce IL-12
in DCs, are equally interesting, because DCs matured by
these LAB do not induce IFN-γ production in NK cells, but,
added together with IL-12-inducing LAB, they reduce IL-12
production by DCs and thereby IFN-γ production by NK
cells. Although the ratio of IL-10/IL-12 induced by non-IL-
12-inducing LAB is high, IL-10 is not responsible for this
suppression [14]. Rather, LAB with diﬀerent properties may
compete for receptor sites including TLR2 [73]. In addition,
when coculturing NK cells with DCs matured by LAB,
irrespective of their IL-12-inducing capacities, increased NK
cell proliferation and cytotoxicity can be observed [14].
Thus, some LAB might actively contribute to Th1 skewing
via the intermediate of NK cells producing IFN-γ whereas a
broader panel of LAB strains may increase NK cell number
and cytotoxic potential owing to their mutual interaction
with dendritic cells (Figure 1).
8.Gut-DerivedLABInduceSpecies-Dependent
IFN-γ Releaseby NK Cellsvia DC Activation
In a study comparing three LAB (L. acidophilus, L. reuteri,
and B. biﬁdum), only DCsmatured byL. acidophilus induced
high amounts of IFN-γ release by NK cells, suggesting that
not all LAB have this capability [14]. It is generally accepted
that IL-12 induces IFN-γ production in human NK cells [4].
IFN-γ production by NK cells is required to induce Th1
responses in lymph nodes [78], emphasizing the importance
of bacterial regulation of IL-12 production in DCs. Remark-
ably, it is still not completely elucidated how L. acidophilus
induces IL-12 production in DCs, although the mechanism
involves recognition by TLR2 [73] and phagocytosis [79].Journal of Biomedicine and Biotechnology 5
NK cell activation, proliferation,
and cytotoxic activity
LAB
iDC activation
IFNγ, TNFα,
GM-CSF
Th1 response
IL-12, IL-15,
IFNα/β
iDC
DC
iDC activation
NK
NK NK
Figure 1: Bi-directional activation between dendritic cell and
natural killer (NK) cells in the presence of commensal bacteria.
Immature dendritic cells (iDC) are activated and matured by
commensal bacteria, for example, lactic acid bacteria (LAB). These
LAB-activated mature dendritic cells (DC) produce cytokines able
to activate NK cell cytotoxicity and induce their proliferation.
Activated NK cells can in turn, via the release of relevant cytokines,
recruit (GM-CSF) and activate iDC (TNF-α and IFN-γ). Alterna-
tively, activated NK cells can exert an editing of DC by killing some
of the iDC. At the same time, the early release of IFN-γ by NK
cells interacting with LAB-activated DC, most likely in secondary
lymphoid organs such as the mesenteric lymph nodes, is critical for
shaping the following adaptive immune response toward a type 1
T cell response. Remarkably, some LAB display opposite outcomes
and could hamper T cell type 1 polarization.
This corresponds to Michelsen et al. [80], who showed
that maturation and IL-12 production can be induced in
murine DCs via TLR2 recognizing puriﬁed peptidoglycan
and lipoteichoic acid. Of note, IL-12 induction in mDC by
strongIL-12-inducingLABsuchasL.acidophilushasrecently
been shown to be preceded and partially depend on IFN-
β production by the same cells [79]. How this early IFN-
β production may aﬀect the DC’s interaction with NK cells
remains to be investigated.
Being non-IL-12 inducing LAB strains, B. biﬁdum and
L. reuteri inhibit L. acidophilus-induced IL-12 production
in DCs and, accordingly, abrogate IFN-γ production by NK
cells [14]. This dominant IL-12-inhibitory property of a
m i x t u r eo fL A Bm a yb eo fi m p o r t a n c ei nt h ei n t e s t i n ew h e r e
a large variety of distinct species coexists. The inhibitory
components of these bacteria are seemingly soluble and may
highlight that such compounds reach gut DC compartments
that intact bacteria do not usually access [14, 73].
9.LABIncreasing In Vivo NK Cell
CytotoxicPotential
A number of probiotic LAB, both IL-12-inducing and non-
IL-12-inducing strains, have been tested for their ability to
increase in vivo NK cell activity as a measure of innate
immune activity. Intervention studies have been conducted
in healthy volunteers, in which the cytolytic potential of
NK cells against standard tumor target cell lines has been
measured at several stages of the intervention. Strong
evidence of an increase in NK cell activity after probiotic
supplementation has been found in elderly individuals [81–
83]andinhabitualsmokers[84].Often,theincrementinNK
cell cytolytic activity is lost when probiotic supplementation
is terminated [82, 83], reﬂecting that probiotic bacteria
hardly permanently colonize the host. DCs, and not other
accessory cells, are likely to be the cell type responsible
for the increase in NK cell activity, as DCs present in
Peyer’s patches and the lamina propria of the intestine
have access to the commensal microﬂora and continuously
migrate to mesenteric lymph nodes [84]. In a human study
comparing intake of ﬁbre and L. casei to reduce recurrence
of colon tumors, L. casei administration was the preferred
intervention [85]. In mice, increased cytolytic potential of
NKcellsafteringestingprobioticbacteriahasbeencorrelated
to reduction in tumour incidence [86]. In these studies,
however,inadditiontoadirecteﬀectofNKcellsontumours,
NKcellsactivation mayhavepromotedTh1 polarization and
thereby a cytotoxic T cell antitumour response. Investigators
have attempted to assign the increase in NK cytolyticactivity
to an increase in NK cell number or in per-cell cytotoxicity,
since both phenomena indeed occur [82, 87].
10.Direct StimulationofNK Cellsby LAB
Direct interaction between LAB and NK cells may occur in
the epithelium, where NK cells reside among the intraep-
ithelial lymphocytes [78]. Even if NK cells have previously
been shown to be the lymphocyte population most sensitive
to activation by LAB, it happens only in the presence of
innate accessory cells [88]. These observations, however,
do not rule out that NK cells in the gut may be able
to directly detect LAB, possibly by interaction between
bacterial CpG DNA and TLR9, which is present in NK
cells [39]. Studying the direct eﬀect of LAB stimulation on
both polyclonally activated and nonactivated NK cells, IFN-
γ production was not observed (L.N.F, unpublished data),
suggesting that LAB do not interact with TLR9 on NK
cells, but rather with TLR2 on accessory cells. TLR2 has
been shown to be absent or expressed in low amounts in
NK cells [89, 90], and its ligation only activates NK cells
in the presence of exogenous IL-12 [91]. On the contrary,
induction of cytotoxic activity in NK cells by LAB has been
observed both in the presence and absence of accessory cells
[92].
To our knowledge, only Yun and colleagues [93]h a v e
observed a direct stimulatory eﬀect of gastro-intestinal
bacteria on cytokine production by highly pure NK cells
using Helicobacter pylori. This bacterium may interact with
one of the TLRs shown to be functional in NK cells
recognizing bacterialproducts:TLR5thatbindsﬂagellin [94]
and TLR9 that detects unmethylated CpG motifs in bacterial
DNA [39], and not TLR2, which is expected to be the main
receptor involved in the recognition of LAB [95].6 Journal of Biomedicine and Biotechnology
11.RoleofNK CellsinTh1Polarizationby LAB
Consumption of certain LAB has been shown to alleviate
allergy [96, 97]. Matsuzaki and colleagues [98]o b s e r v e d
that oral administration of Lactobacillus casei,s t r a i nShirota
(LcS), enhance innate immunity by stimulating the activity
of splenic NK cells. Oral feeding with killed LcS was able
to stimulate the production of Th1 cytokines, resulting in
repressed production of IgE antibodies against ovalbumin
in experimental mice. It is believed that LAB skew the
allergic Th2 response to a Th1 response via the induction
of IL-12 in antigen-presenting cells. Interestingly, NK cells
are considered to play a key role in the induction of Th1
responses. It is not known whether NK cells secreting IFN-
γ after interaction with DCs participate in Th1 polarization
by LAB in vivo. Although the link between in vitro and in
vivo activation of NK cells by LAB remains to be established,
LAB may become a valuable tool to promote NK activation
and thereby Th1 polarization, both as oral adjuvants and
as stimulators of DCs exploited in immunotherapy. In
addition, the presence of LAB early in life, deﬂecting the
immune system towards a Th1 response, possibly through
the intermediate NK cells, may aid in the prevention of
Th2-mediated allergy. Finally, the evidence that weak IFN-γ-
inducing LAB species are able to suppress the action of IFN-
γ-inducing species while preserving NK cell-stimulatory
activity could represent a pivotal mechanism in maintaining
immunological homeostasis in the intestine or for contrast-
ing Th1-mediated autoimmune diseases, such as Crohn’s
disease or even celiac disease. Moreover, LAB may represent
a useful tool for modulating the cytokine balance during
autoimmune diseases driven by Th17 cells in the absence of
IFN-γ [99].
12.ConcludingRemarks
Commensal bacteria are known to be involved in the
maintenance of gut immune homeostasis, and now also
emerge as potential NK cell modulators [14]. The crosstalk
betweenNKcellsand DCssuggestsa criticalrole forNKcells
in the initiation and regulation of immune responses. The
considerableknowledgeonthemolecularbasisofthesecellu-
lar interactions oﬀers opportunities for clinical intervention
exploiting DC/NK cell cooperation. For instance, LAB
mediate, via DC maturation, proliferation of NK cells and
increase of their cytotoxicity.This indicates that LAB, similar
to pathogenic microorganisms and inﬂammatory stimuli,
allow DCs to signal to NK cells. Stimulation of NK cell
proliferation and cytotoxicity can, therefore, be considered
a general ability of LAB. An enlarged and more cytolytic
pool of NK cells would be beneﬁcial prophylactically in
healthy individuals but also therapeutically in many disease
conditions.
Puriﬁed NK cells rarely respond to commensal bacteria,
andtheiractivationapparentlyrequiresthepresenceofeither
pDCsormyeloid DCs,dependingonthestimulus.Aconcept
emerging from data regarding the crosstalk NK/pDCs is that
type I IFN released by pDCs is a potent inducer of NK
cell cytotoxicity, suggesting that interaction of NK cells with
pDCs can result in enhanced antiviral innate protection.
Furthermore, the mucosal microﬂora might be able to
regulate IFN-α production by activated pDCs, although
further research is currently highly required in this ﬁeld of
investigation [63, 64].
More generally, the regulatory role of DCs by LAB
is of particular importance at mucosal surfaces such as
the intestine, where the immune system exists in intimate
association with the commensal bacteria [11]. It has been
shown that diﬀerent species of LAB posses the ability to
ﬁnely regulate myeloid DCmaturation andtheir interactions
with NK cells, polarizing the subsequent T cell activity
toward Th1, Th2, or even Treg responses [12–14]. This
network can, therefore, control not only the strength and the
quality of innate responses but also the subsequent adaptive
responses, via both cell-to-cell interactions and cytokine
release.
In conclusion, LAB potently initiate NK/DC interactions
via DC maturation and, as a consequence of that, NK
cells increase their cytolytic potential. However, diﬀerent
commensal bacteria have diﬀerent eﬀects on IFN-γ pro-
duction by NK cells [14]. Since Th1-promoting LAB or
their inhibitory counterpart (non-IL-12-inducing LAB) can
easily be identiﬁed, these LAB strains may represent a useful
tool for modulating the cytokine balance and to promote
potent type-1 immune responses, as required in infection
and cancer, or to contrast immune dysregulation associated
to speciﬁc T cell polarization.
All these considerations provide a strong rationale for
a combined targeting of NK cells and LAB-stimulated
DCs in novel immunotherapeutic strategies, exploiting this
cellular crosstalk not only in the treatment of intestinal
inﬂammatory diseases but also in many other conditions for
which appropriate immune interventions are required.
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